Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GRK2 | P25098 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22504989 | 0.95 | ALDH1A1 (0.49) | ALDH1A1ALOX15TDP1L3MBTL1POLB | |
| SCHEMBL27628750 | 0.76 | SMN1; SMN2 (0.49) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 | |
| SCHEMBL955333 | 0.75 | ALDH1A1 (0.49) | ALDH1A1ALOX15TDP1TAAR1SMN1; SMN2 | |
| SCHEMBL955334 | 0.75 | ALDH1A1 (0.44) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 | |
| SCHEMBL987088 | 0.74 | ALDH1A1 (0.55) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 | |
| SCHEMBL10378541 | 0.73 | ALDH1A1 (0.43) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 | |
| SCHEMBL988106 | 0.73 | ALDH1A1 (0.50) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 | |
| SCHEMBL17373980 | 0.72 | ALDH1A1 (0.43) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 | |
| SCHEMBL7919931 | 0.72 | ALDH1A1 (0.43) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 | |
| SCHEMBL7931579 | 0.72 | ALDH1A1 (0.43) | ALDH1A1ALOX15TAAR1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10442981-B2 | Hydroxypropyl betaine based zwitterionic geminal liquids, obtaining process and use as wettability modifiers with inhibitory/dispersants properties of asphaltenes | INSTITUTO MEXICANO DEL PETRÓLEO (MX) | 2019-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10442981-B2 | Hydroxypropyl betaine based zwitterionic geminal liquids, obtaining process and use as wettability modifiers with inhibitory/dispersants properties of asphaltenes | GEMIN5, GEMIN4, DHCR7 | ALDH1A1 4493/4885ALOX15 1028/4885TDP1 2012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.